Binnacle Investments Inc Neurocrine Biosciences Inc Call Options Transaction History
Binnacle Investments Inc
- $137 Billion
- Q1 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding NBIX
# of Institutions
648Shares Held
99.1MCall Options Held
698KPut Options Held
522K-
Black Rock Inc. New York, NY14.2MShares$1.71 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.94MShares$1.2 Billion0.02% of portfolio
-
Dodge & Cox San Francisco, CA5.53MShares$667 Million0.37% of portfolio
-
State Street Corp Boston, MA4.86MShares$586 Million0.02% of portfolio
-
Jpmorgan Chase & CO New York, NY2.67MShares$322 Million0.02% of portfolio
About NEUROCRINE BIOSCIENCES INC
- Ticker NBIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 95,639,296
- Market Cap $11.5B
- Description
- Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...